# Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy

> **NCT02001519** · PHASE2 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 88 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** AC4-CDDP4

## Key facts

- **NCT ID:** NCT02001519
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-02
- **Final completion:** 2014-07
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2014-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02001519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02001519, "Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02001519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*